Korea United Pharm Inc. logo

Korea United Pharm Inc. (033270)

Market Closed
15 Jun, 06:30
KRX SM KRX SM
18,650. 00
+150
+0.8108%
293.2B Market Cap
- P/E Ratio
1,800% Div Yield
13,706 Volume
- Eps
18,500
Previous Close
Add Transaction
Day Range
18,590 18,870
Year Range
17,400 22,450
Want to track 033270 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

033270 closed today higher at ₩18,650, an increase of 0.8108% from yesterday's close, completing a monthly decrease of -0.2674% or -₩50. Over the past 12 months, 033270 stock lost -2.4582%.
033270 pays dividends to its shareholders, with the most recent payment made on Apr 14, 2026. The next estimated payment will be in In 9 months on Apr 14, 2027 for a total of ₩450.
The last earnings report, released on Apr 27, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Korea United Pharm Inc. has completed 2 stock splits, with the recent split occurring on Jan 20, 2014.
The company's stock is traded on one exchange.

033270 Chart

People also search for

Hyundai Motor Co.
647,000
+6.5898%
Hyundai Motor Co. Ltd.
244,500
+4.9356%
Hyundai Motor Co. Ltd. Preferred
256,500
+6.2112%
Hyundai Motor Co., Ltd. Preferred
257,000
+6.639%
Kia Corporation
167,500
+0.4197%

Korea United Pharm Inc. (033270) FAQ

What is the stock price today?

The current price is ₩18,650.00.

On which exchange is it traded?

Korea United Pharm Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 033270.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1,800%.

What is its market cap?

As of today, the market cap is 293.2B.

Has Korea United Pharm Inc. ever had a stock split?

Korea United Pharm Inc. had 2 splits and the recent split was on Jan 20, 2014.

Korea United Pharm Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Duk-Young Kang CEO
KRX SM Exchange
KR7033270000 ISIN
KR Country
- Employees
29 Dec 2025 Last Dividend
19 Feb 2001 Last Split
- IPO Date

Overview

Korea United Pharm Inc. is a distinguished pharmaceutical company based in Seoul, South Korea, founded in 1987. The company specializes in the manufacturing and sale of pharmaceutical products, primarily focusing on the South Korean market. Over the years, Korea United Pharm Inc. has expanded its reach by exporting its products to approximately 40 countries worldwide. The firm has established itself as a significant player in the pharmaceutical industry by offering a wide array of treatments across various medical fields.

Products and Services

  • Respiratory System: Products aimed at treating diseases and conditions affecting the respiratory system such as asthma, chronic obstructive pulmonary disease (COPD), and infections. These offerings are designed to aid in breathing and ensuring proper lung function.
  • Musculo-skeletal System: This category includes drugs for bone and joint health, targeting conditions such as arthritis, osteoporosis, and muscle pain or spasms. The aim is to improve mobility and alleviate pain.
  • Gastro-intestinal Tract System: Products in this area focus on digestive health, including treatments for conditions like acid reflux, ulcers, and irritable bowel syndrome (IBS). They are designed to ensure the proper functioning of the digestive system.
  • Cardiovascular System: Medications to support heart health and treat conditions related to the cardiovascular system such as hypertension, heart failure, and arrhythmias. These are vital in managing and preventing heart diseases.
  • Anti-cancer: A range of oncology drugs aimed at treating various forms of cancer. These products are often part of comprehensive cancer treatment plans, including chemotherapy.
  • Anti-infectives: Antibiotics and antiviral drugs to combat infections. These products are crucial in treating bacterial and viral infections, including those resistant to standard treatments.
  • Allergy: Medications to alleviate symptoms of allergies, such as antihistamines and corticosteroids. These products help manage allergic reactions and improve the quality of life for those with allergies.
  • Immune System: Immunosuppressants and immunomodulators that affect the immune system, useful in treating autoimmune diseases and in organ transplantation.
  • Central Nervous System: Drugs that impact the central nervous system, including treatments for neurological conditions such as epilepsy, depression, and anxiety. These are formulated to maintain and restore normal brain function.
  • Other Diseases: Treatments for a range of other conditions, signifying the company’s commitment to addressing various health concerns beyond their primary focus areas.
  • OTC Drugs: Over-the-counter (OTC) medications that can be purchased without a prescription, including pain relievers, cold and flu treatments, and digestive aids. These products cater to general well-being and symptom relief for common ailments.

Contact Information

Address: Nonhyeon-ro 121street 22, Seoul, South Korea
Phone: 82 2 512 9981